In considering a new strategic plan, Senior Leadership of the Helen Diller Family Comprehensive Cancer Center (HDFCCC); the Director, Deputy Director, and nine Associate Directors) developed the theme of “Cancer Research in 2030:” that is, what will cancer research look like at UCSF in 2030? This forward-looking focus was intended to encourage creativity unconfined by a particular institutional structure or five-year grant mechanism. Furthermore, the motivation for this strategic planning was not in reaction to a specific problem to solve, but rather to think about where cancer research was going in the near future, and with this vision to define an overall scientific direction, mission, and priorities. Focusing on the science and not the requirements of a funding cycle paved the way for an innovative, actionable, and motivating strategic planning process.
This process led to the HDFCCC Research Mission Statement:
Through discovery, clinical, and population science, we will understand the person and their social and physical environment, understand the tumor, and understand the intervention. We will translate this research into appropriate risk stratification, prevention, screening, diagnosis, interventions, and long-term care decisions, and reduce inequities in cancer care and treatment outcomes.
The HDFCCC Cancer Research in 2030 strategic planning process began in 2018 and was divided into three phases as shown below. For more information about the details of process and implementation, view the Strategic Plan online.